Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STA-21 ointment in plaque psoriasis
NCT01047943Phase 2
Key facts
- Status
- Completed
- Start
- Jun 2007
- Primary completion
- Apr 2008
- Countries
- 1
- Sponsor
- Kochi University
- Modality
- Small Molecules
- Drugs
- ochromycinone
- Conditions
- plaque psoriasis
01
Overview
Phase 2, open-label trial of ochromycinone in plaque psoriasis, sponsored by Kochi University. Primary endpoints: Erythema score at 2 weeks, Induration score at 2 weeks and 1 more. Started Jun 2007; status: completed.
02
Design
- Study design
- Non-randomizedOpen-labelSingle group
03
Who it enrols
Adults aged 20-80 with a minimum 2-year history of plaque psoriasis, excluding those with extensive body surface involvement (>40%) or recent systemic, UV, or topical treatments.
04
Endpoints
Primary
Erythema score
Induration score
Scaling score
Beyond the preview
Go deeper on NCT01047943.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01047943.